clearn.png
Thursday February 27th, 2020 10:12PM

Pfizer 1Q profit jumps 9% on higher drug sales, lower costs

By The Associated Press
Related Articles
  Contact Editor

Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit expectations.

Investors drove up Pfizer shares $1.20, or 3%, to $40.79 in early afternoon trading.

Sales of breast cancer drug Ibrance and blood thinner Eliquis both jumped over 20% to more than $1 billion each in the quarter, and Xeljanz for rheumatoid arthritis saw sales soar 30%, lifting prescription drug sales by 3%.

The New York drugmaker on Tuesday reported net income of $3.88 billion, or 68 cents per share. Earnings, adjusted for non-recurring costs, were 85 cents per share, beating analysts' projections by 8 cents.

"Pfizer is off to a very good start in 2019," new Chief Executive Albert Bourla told analysts during a conference call.

Bourla noted Pfizer had several drug approvals in the U.S. or elsewhere during the quarter, including U.S. approval of its biosimilar version, or near-copy, of injected breast and gastric cancer drug Herceptin and approval of Ibrance for men. The company expects U.S. approvals this year for biosimilar medicines for cancer and rheumatoid arthritis, plus approval of tafamadis for a rare, tough-to-diagnose heart disorder with no current treatment.

However, Pfizer's heavily touted experimental pain drug tanezumab flopped in late-stage testing, so its future is in doubt.

"We continue to like (Pfizer) given what we see as an emerging new product story that we believe provides an attractive risk/reward" balance, Credit Suisse analyst Vamil Divan wrote to investors. He attributed the profit beat to a mix of better-than-expected gross margin, lower taxes and research spending, and fewer outstanding shares.

The biggest U.S. drugmaker by revenue posted sales of $13.12 billion, up from $12.91 billion in 2018's first quarter.

Under Bourla, Pfizer reorganized yet again this year, with three slightly tweaked business segments: consumer health, which sells staples such as Advil pain reliever, Chapstick and Centrum vitamins; the biopharmaceuticals group selling new medicines, and its off-patent medicines business, named Upjohn for one of the many drug companies that Pfizer gobbled up in recent decades.

Prescription drug sales totaled $9.19 billion, led by pneumococcal vaccine Prevnar 13, the world's top-selling vaccine ever, with sales of $1.49 billion in the quarter. Pfizer and rival Merck & Co., maker of Pneumovax, both are developing improved versions of their vaccines that block more strains of the bacteria, which cause pneumonia and ear and bloodstream infections.

Upjohn sales fell 1% to $3.08 billion. Over a third of that came from fibromyalgia and pain medicine Lyrica, which was just shifted into the Upjohn business because U.S. generic competition starts after June 30.

Consumer health sales dropped 5% to $858 million, but Pfizer's revenue from partnerships jumped 27% to $1.1 billion.

Meanwhile, Pfizer said it will make significant improvement by year's end to sterile injectable medicine factories it's been upgrading extensively since buying them from Hospira a few years ago. The work has limited production, causing lengthy shortages of medicines crucial for hospitals. Pfizer wouldn't say when the work will wrap up.

Pfizer Inc. raised its full-year profit forecast by a penny, to $2.83 to $2.93 per share. It reaffirmed its January forecast for sales of $52 billion to $54 billion.

___

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

  • Associated Categories: Associated Press (AP), AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2020 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
The Latest: Facebook CEO declares 'the future is private'
The Latest: Facebook CEO declares 'the future is private'
1:44PM ( 13 minutes ago )
Top White House adviser says Trump still backing Moore
Top White House adviser Kellyanne Conway says Trump still backing Stephen Moore for Fed job
1:39PM ( 19 minutes ago )
Dems say Trump agrees to $2 trillion infrastructure tab
President Donald Trump and Democratic leaders agreed Tuesday on how much they would like to spend on an infrastructure bill, but now comes the hard part
1:35PM ( 23 minutes ago )
Associated Press (AP)
The Latest: Venezuela envoy denies US role in revolt
The ambassador to Washington representing Venezuelan opposition leader Juan Guaidó says the U.S. played no role in coordinating the uprising in Caracas against President Nicolás Maduro
1:20PM ( 37 minutes ago )
The Latest: UN chief urges 'maximum restraint' in Venezuela
The U.N. says Secretary-General Antonio Guterres is urging all sides in Venezuela to exercise "maximum restraint," avoid any violence and take immediate steps to restore calm
1:07PM ( 50 minutes ago )
The Latest: Internet restrictions reported in Venezuela
An online censorship-monitoring group says Venezuela's state-run internet provider has been restricting access to YouTube and some Google services
12:55PM ( 1 hour ago )
AP Business
Revenue slowdown at Alphabet helps drag US stocks lower
U.S. stocks are moving lower in morning trading, dragged down by big communications companies after Google's parent company, Alphabet, reported a slowdown in revenue growth. Investors
11:32AM ( 2 hours ago )
Russian oil firm asks for probe of contaminated supply
A Russian oil company has asked state security services to investigate a small private company accused of pushing contaminated oil through an export pipeline to Belarus
10:59AM ( 2 hours ago )
Merck 1Q net quadruples as cancer drug, vaccine sales soar
Surging sales of vaccines, cancer blockbuster Keytruda help Merck quadruple first quarter profit and blow past Wall Street expectations
10:51AM ( 3 hours ago )
AP Business - Corporate News
Infrastructure bringing together Trump, Democratic leaders
President Donald Trump and Democratic leaders begin their search Tuesday for a compromise on boosting the nation's roads, bridges and other infrastructure.
11:09AM ( 2 hours ago )
Trump lawsuit tries to block subpoenas for financial records
A lawsuit filed by President Donald Trump and the Trump Organization says congressional subpoenas issued for his financial records are unlawful
11:03AM ( 2 hours ago )
The Latest: WH seems to rule out gas tax hike for repairs
The White House says President Donald Trump is the "guy who lowers taxes," appearing to rule out hiking the federal gasoline tax to pay for infrastructure repairs
10:47AM ( 3 hours ago )
AP Business - Industries
Stocks edge higher on Wall Street after record-setting week
US stocks edge higher as banks benefit from a report showing that consumer spending surged last month, clocking its biggest gain in almost a decade.
1:46PM ( 1 day ago )
US judge in Washington state blocks new Trump abortion rule
A US judge in Washington state has blocked new Trump administration rules that could cut off federal funding for health care providers who refer patients for an abortion
9:27PM ( 4 days ago )
Video game effort could help regulate future drone traffic
Drones ferrying medical supplies, packages and even pizza could one day be crisscrossing the skies above U.S. cities, and a team at the University of Utah is working with regulators to keep that future traffic in check using a video game
4:58PM ( 4 days ago )
AP Business - Health Care
The Latest: Facebook CEO declares 'the future is private'
The Latest: Facebook CEO declares 'the future is private'
1:44PM ( 13 minutes ago )
Top White House adviser says Trump still backing Moore
Top White House adviser Kellyanne Conway says Trump still backing Stephen Moore for Fed job
1:39PM ( 19 minutes ago )
Dems say Trump agrees to $2 trillion infrastructure tab
President Donald Trump and Democratic leaders agreed Tuesday on how much they would like to spend on an infrastructure bill, but now comes the hard part
1:35PM ( 23 minutes ago )
Berkshire steps into fight for Anadarko on Occidental's side
Berkshire Hathaway puts up $10 billion in financing for Occidental in Anadarko buyout, potentially upending bid by Chevron
1:31PM ( 26 minutes ago )
McDonald's turns to bacon and wins (surprise, surprise)
Just add bacon: McDonald's tops 1Q expectations as same-store sales jump 5.4%
1:25PM ( 32 minutes ago )